Clearing the Air on GLP-1: What the Research Actually Shows
- Burgess Buchanan
- Apr 22
- 3 min read
There’s a lot of noise around GLP-1 medications and I’ll be the first to admit, I used to be part of that noise. Earlier in my career as a nurse practitioner, I was skeptical. I believed many of the common concerns circulating online and in clinical spaces. But as I dug deeper into the research, I realized I had been misunderstanding these medications. This post is about setting that straight by focusing on what the evidence actually shows, not opinions or trends.
Let’s start with the basics.
What Are Peptides?
Peptides are short chains of amino acids that act as signaling molecules in the body. Think of them as messengers helping different systems communicate and function properly. Your body naturally produces many peptides that regulate processes like metabolism, appetite, inflammation, and blood sugar.
One of those naturally occurring peptides is GLP-1, also known as glucagon-like peptide-1.
What Does GLP-1 Do?
GLP-1 is a hormone your body already makes, primarily in the gut. It plays a key role in regulating blood sugar by stimulating insulin release, slowing gastric emptying so you feel full longer, and reducing appetite by signaling satiety to the brain.
GLP-1 receptor agonist medications are designed to mimic and enhance these natural effects. They are not foreign in the sense that they activate a pathway your body already uses.
Where Things Go Wrong
Despite their benefits, GLP-1 medications are often misused. This is where many of the concerns you may have heard actually come from, and some of them are valid.
These issues include lack of proper medical oversight, use in patients who do not truly need them, staying on them indefinitely without a plan, and ignoring foundational lifestyle factors.
One of the most overlooked problems is inadequate protein intake. Because appetite is reduced, many patients unintentionally under-eat protein. This can lead to loss of lean muscle mass and a slower metabolism over time. Patients on GLP-1 medications should generally aim for around 1.6 to 2.0 grams of protein per kilogram of body weight daily to support muscle and metabolic health.
Fiber intake is another key factor that is often neglected. Adequate fiber supports digestion, gut health, satiety, but also metabolism. Without it, patients may experience constipation and less optimal metabolic outcomes.
What the Research Actually Shows
When used appropriately, GLP-1 medications are backed by strong clinical evidence.
In terms of weight loss, studies show meaningful and sustained reductions in body weight for many patients. When combined with adequate protein intake and resistance training, improvements in body composition are also seen.
Beyond weight loss, research shows improved blood sugar control, reduced risk of cardiovascular events in certain populations, and broader benefits to metabolic health.
These are clinically meaningful outcomes that can have a real impact on long-term health.
The Bigger Picture
GLP-1 medications are tools & they shouldn't be the only tools.
Your body already produces GLP-1. These medications simply enhance a natural system that regulates hunger, metabolism, and blood sugar. When used thoughtfully with proper guidance, nutrition, and lifestyle support, they can be very effective.
But when used without structure, education, or attention to the foundations of health, they can fall short or create new challenges.
Final Thoughts
If there is one thing I have learned, it is that the conversation around GLP-1 medications needs more nuance. If you are interested in learning more about the GLP1s Origo Functional Medicine offers, please call or fill out the contact form on the main page.


Comments